Spring 2021 Papers

J.A.
Investing in Global Health Innovations: A Decision-Making Framework

Andrew Barnett
Applying Precision Medicine to Long-Term Care Insurance

Slidedeck

Kate Buellesbach
It’s a Woman’s World: Femtech for the 21st Century

Kellyann Burlage
Venture Opportunities in Women’s Health: Closing the Gender Health Gap

Slidedeck

Cam Burton
Shifting Incentives: Exploring the future of Personalized medicine In the biotechnology industry
   

Pam Cai
Comparison of the investment size and returns in tech vs. biotech companies

Skyler Castillo-Wilson
Alternative Advanced Degree Funding Model for Accelerated Research and Discounted Equity Rates

Ben Conrad
Medicare Advantage: Understanding the Program & Two New Innovative Upstarts
  

Caroline Dunn
RETHINKING THE MENTAL HEALTH PSYCHIATRY MODEL WITH TELEMEDICINE

Slidedeck

Jacob Edelson
CRISPR Start-ups that Pivoted to COVID-19 Testing
 

Areian Eghball
Mental Health Thesis Making sense of a crowded space

Slidedeck

Ahmed Elbakri
Regulatory Planning and Budgeting for the Commercialization of AI-Enabled Rapid Diagnostics Platforms – A Guide for Diagnostics Entrepreneurs

Christopher Fisher
Medical Device Innovations – A review of founder and investor perspectives

Grace Catherine Benoist Fish
2021 Venture Capital Opportunities in the Mental Healthcare Space

Nicolas Garcia
Funding The “Full-Stack” Doctor – The role VC can play in the Healthcare of the Future

Slidedeck

Betty Ha
2020s The Age of Biotech
 

Stephanie Huang
The Roaring 20’s as the decade of biotech

Sanjay Iyer
The Role of Artificial Intelligence in Digital Health

Kathy Ku
Recents Trends in Women’s Health Consumer Brands

Esmond Lee
How universities can Bridge the Biotech Valley of Death for Cell & Gene Therapies

PJ Loury
Liquid Biopsy: Integral to the next generation of cancer treatment?

Ricardo Jacob Mack
The Relationship of Healthcare Affordability and Biotech Industry
paper

Angel Madero
Healthcare and Biotech in Latin America

Ben Marafino
Growing diseconomies of scale in pharmaceutical R&D productivity and manufacture will likely compound “payer-reluctance risk” for novel therapeutics

Vincent Masto
SPACs in biotech are here to stay

Slidedeck

Samson Joel Mataraso
Incentivizing Investment in Antibiotic Development to Tackle Rising Antibiotic Resistance

Yanick Mulumba
The role of patents in valuation of biotech companies: A case study

Floriane Ngako Kameni
Investing in Health Equity

Brandon Nydick
Evaluating Medical Device Startups: A Quantitative Framework for Venture Capitalists

Pettie Kade Ploussard
ML-guided biomolecule evolution companies are more numerous than they appear

Megan Roche, MD
Women in Venture Capital: How Underrepresentation Impacts Business And Society

Powerpoint

Slidedeck

Sarah Runkle
“We’re Not a Vitamin Company, We’re a Tech Company”
A memo for investors considering the supplements space
 

Jarod Rutledge
An Investment Assessment of Emerging Science in Longevity Biotechnology

Donya Sarrafian
IP Protection & the Case for 100 Year Patents

Powerpoint

Slidedeck

A.I.S.
Value-Based Pharmaceutical Pricing:
A Framework for Addressing High Drug Costs

Slidedeck

Youngyoon Amy Seo
Incyte Corporation: A venture capitalist’s dream

Slidedeck

Shannon Kayj
Creating Biological Systems Overview

Slidedeck

Diva Sharma
Healthcare Financing Companies Need A More Contrarian Approach to Scale Quicker

Slidedeck

M. T.
Optimizing the Clinical Trial 

Joan E. Thompson
Gender Imbalance in Healthcare Venture Capitol:
Reviewing Market Perspectives on Arbitage & Parity

Slidedeck

Zach Walters
Precision Medicine and Mental health

Slidedeck

Victor Yin
Hong Kong Biotech IPOs
    

Jenna Fisher Zerker
Digital Health–A Growing Opportunity 

Yihui Zhang
Funding for Cure: A Scoring Framework to Invest the Best Science